OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Platelet Count Abnormal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 5,951 reports · 138 co-occurring drugs

As of the last recalculation, Platelet Count Abnormal appears in 5,951 FAERS reports alongside 138 co-occurring drug terms. The strongest observed disproportionality signal is ROMIPLOSTIM (PRR 265.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Romiplostim958265.1283.1
Eltrombopag Olamine48580.081.7
Ruxolitinib78343.944.3
Hydroxyurea11619.519.7
Eculizumab28118.919.0
Niraparib11218.018.1
Avapritinib5816.917.0
Alemtuzumab7513.713.8
Venetoclax21212.412.5
Tranexamic Acid3011.911.9
Ribociclib879.89.8
Acalabrutinib308.78.7
Ibrutinib1878.38.3
Ifosfamide487.97.9
Azacitidine637.57.5
Nilotinib607.27.2
Bosutinib187.07.0
Daspone196.86.9
Dapsone Gel, 5%196.86.9
Azacitidine For356.86.8
Fulvestrant636.76.7
Dapsone196.26.3
Febuxostat Tablets 40 Mg186.26.2
Febuxostat Tablets 80 Mg186.26.2
Filgrastim646.06.0
Ixazomib496.06.0
Erythropoietin356.06.0
Human Immunoglobulin G335.65.6
Cytarabine885.25.2
Brentuximab Vedotin155.15.1
Blinatumomab155.05.0
Letrozole Tablets674.94.9
Selinexor124.94.9
Imatinib244.84.8
Prochlorperazine Maleate124.64.6
Letrozole764.44.4
Rituximab2454.24.2
Febuxostat204.24.2
Ursosiol224.04.0
Rucaparib104.04.0
Carfilzomib313.83.9
Temozolomide233.83.8
Posaconazole Delayed-Release123.83.8
Thiamine Hydrochloride, Riboflavin 5 Phosphate Sodium, Dexpanthenol And Niacinamide333.83.8
Dexamethasone Sodium Phosphate113.83.8
Acyclovir1213.83.8
Olaparib223.73.7
Ursodiol223.53.5
Etoposide723.53.5
Doxorubicin Hydrochloride323.43.4
Deferasirox263.43.4
Vincristine Sulfate283.43.4
Palbociclib863.23.2
Bendamustine Hcl143.23.2
Allopurinol1343.03.0
Daptomycin83.03.0
Cisplatin673.03.0
Obinutuzumab143.03.0
Oxaliplatin622.92.9
Dexamethasone 1.5 Mg2372.92.9
Carboplatin1032.92.9
Dexamethasone2372.92.9
Posaconazole132.82.8
Cyclosporine862.72.7
Vitamin C712.72.7
Chlorthalidone92.72.7
Losartan Potassium And Hydrochlorothiazide92.72.7
Ondansetron Hydrochloride942.72.7
Prochlorperazine212.72.7
Iron502.62.6
Atovaquone62.62.6
Ravulizumab102.62.6
Metoprolol Succinate Er Tablets462.62.6
Gemcitabine292.62.6
Thiotepa72.62.6
Mesna Injection62.52.5
Rifaximin152.52.5
Metoroprolol Tartrate472.52.5
Enoxaparin Sodium412.52.5
Mesna62.52.5
Pazopanib Hydrochloride192.52.5
Ondansetron762.52.5
Ondansetron Tablets762.52.5
Gemcitabine Hydrochloride372.42.4
Mercaptopurine122.42.4
Prasugrel Hydrochloride72.42.4
Rizatriptan Benzoate72.42.4
Imatinib Mesylate192.42.4
Valacyclovir282.42.4
Metoprolol Succinate582.42.4
Bendamustine Hydrochloride82.32.3
Peginterferon Alfa-2A362.32.3
Pravastatin Sodium132.32.3
Mycophenolic Acid212.32.3
Pembrolizumab682.32.3
Zoledronic Acid262.32.3
Losartan1112.22.2
Panitumumab102.22.2
Famotidine732.22.2
Doxorubicin552.22.2
Cyclophosphamide Injection, Solution1082.22.2
Cyclophosphamide1082.22.2
Cyclophosphamide For Injection1082.22.2
Pemetrexed132.12.1
Lenalidomide2482.12.1
Metoprolol1502.12.1
Dasatinib222.12.1
Apixaban392.02.0
Pemetrexed Disodium211.91.9
Capecitabine461.81.8
Darbepoetin Alfa271.81.8
Vibegron41.71.7
Dronedarone51.71.7
Bleomycin Sulfate51.71.7
Irinotecan Hydrochloride61.61.6
Fesoterodine Fumarate51.61.6
Fluorouracil Cream, 0.5%351.61.6
Pegfilgrastim451.61.6
Fluorouracil351.61.6
Cabozantinib211.51.5
Axicabtagene Ciloleucel41.41.4
Bortezomib361.41.4
Abemaciclib81.41.4
Pomalidomide411.41.4
Sunitinib Malate151.31.3
Dofetilide41.31.3
Alpelisib31.21.2
Tolvaptan51.21.2
Dabigatran Etexilate261.21.2
Osimertinib101.11.1
Atezolizumab121.11.1
Polatuzumab Vedotin31.11.1
Lutetium Lu 177 Vipivotide Tetraxetan41.11.1
Trifluridine And Tipiracil31.01.0
Ledipasvir And Sofosbuvir50.90.9
Velpatasvir And Sofosbuvir30.80.8
Voxelotor40.60.6
Salicylic Acid60.40.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.